IL-17A inhibitor listed on the PBS for ankylosing spondylitis

The PBS listing for ixekizumab (Taltz) has been extended to include adult patients with active ankylosing spondylitis (AS). Ixekizumab was already available on the PBS for severe psoriatic arthritis and severe chronic plaque psoriasis. The PBAC’s decision to recommend the new PBS listing was made largely on the basis of evidence from the COAST and ...

Already a member?

Login to keep reading.

© 2021 the limbic